| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 06/29/2006 | CA2592009A1 Quinoline derivative, its use, production and pharmaceutical agents containing the latter |
| 06/29/2006 | CA2591946A1 Substituted heterocyclic compounds and methods of use |
| 06/29/2006 | CA2589877A1 Carbamate substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors |
| 06/29/2006 | CA2589779A1 Benzamide substituted imidazo- and pyrolo-pyridines as protein kinase inhibitors |
| 06/29/2006 | CA2588474A1 Inhibitors of akt activity |
| 06/29/2006 | CA2588220A1 Heteroaromatic derivatives useful as anticancer agents |
| 06/28/2006 | EP1673371A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 06/28/2006 | EP1673343A2 Compounds and compositions as protein kinase inhibitors |
| 06/28/2006 | EP1673339A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/28/2006 | EP1673088A1 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo¬2,3-c|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 06/28/2006 | EP1673087A2 Alkoxy substituted imidazoquinolines |
| 06/28/2006 | EP1673059A2 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 06/28/2006 | EP1554276B1 Non-nucleoside reverse transcriptase inhibitors |
| 06/28/2006 | EP1395261B1 Pyridylpyrimidine derivatives as effective compounds against prion diseases |
| 06/28/2006 | CN1795196A Agent for repairing corneal sensitivity containing amide compound |
| 06/28/2006 | CN1795195A Pyridopyrazines and the use thereof as kinase inhibitors |
| 06/28/2006 | CN1795194A Pyridopyrazines and the use thereof as kinase inhibitors |
| 06/28/2006 | CN1795188A Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/28/2006 | CN1795177A 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 06/28/2006 | CN1793144A Process for complete synthesizing quinamide of diji frog of high antimer pure nutural |
| 06/28/2006 | CN1261433C 1,3,8-triaza-spiro[4,5]decan-4-one derivs. as neurokinin receptor antagonists |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067662 CXCR3 antagonists |
| 06/27/2006 | US7067658 Anxiolytic agents; antidepressants; Alzheimer, Huntington, Parkinson disease |
| 06/27/2006 | US7067656 Sulfamoyl compounds and agricultural and horticultural fungicides |
| 06/27/2006 | US7067551 Deacetylase inhibitors |
| 06/27/2006 | US7067534 Melanin-concentrating hormone; N-(N'-substituted indolyl)methyl-4-(m-alkylamidophenyl) piperidine; antidepressants, anxiolytic agents; obesity, incontinence |
| 06/27/2006 | US7067531 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent |
| 06/27/2006 | US7067528 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067519 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 06/27/2006 | US7067114 Delivery of antihistamines through an inhalation route |
| 06/22/2006 | WO2006066183A2 Novel saframycin analogs as therapeutic agents |
| 06/22/2006 | WO2006065853A2 Crystalline forms of a factor xa inhibitor |
| 06/22/2006 | WO2006065703A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 06/22/2006 | WO2006065654A1 Bridged ring nk1 antagonists |
| 06/22/2006 | WO2006065601A2 Inhibitors of akt activity |
| 06/22/2006 | WO2006065479A2 Substituted phenols as active agents inhibiting vegf production |
| 06/22/2006 | WO2006065280A2 Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
| 06/22/2006 | WO2006065216A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | WO2006065215A1 Novel compounds |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064484A1 Azabicyclononene derivatives as renin inhibitors |
| 06/22/2006 | WO2006064355A2 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 06/22/2006 | WO2006064339A1 Chromane derivatives useful as acid pump antagonists |
| 06/22/2006 | WO2006064251A1 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 06/22/2006 | WO2006063820A1 Pyrazolo-heteroaryl compounds useful to treat tnf-alpha and il-1 mediated diseases |
| 06/22/2006 | WO2006063805A1 3-amino-pyrazolo[3,4b]pyridines used as inhibitors of protein tyrosine kinases for treating angiogenic, hyperproliferative or neurodegenerative diseases |
| 06/22/2006 | WO2006063709A1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer’s disease |
| 06/22/2006 | WO2006063610A1 Heteroaryl substituted diazabicyclononene derivatives |
| 06/22/2006 | WO2006036932A3 Sulfonamides and uses thereof |
| 06/22/2006 | WO2006036883A3 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases |
| 06/22/2006 | WO2005123079A3 Urea substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| 06/22/2006 | WO2005044795A8 Process for the preparation of ccr-2 antagonist |
| 06/22/2006 | US20060135774 Method for producing pigment transparent preparations based on perylene-3,4,9,10-tetracarboxylic acid diimine |
| 06/22/2006 | US20060135768 Synthesis for hydroxyalkylated heterocyclic bases |
| 06/22/2006 | US20060135575 2-Acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
| 06/22/2006 | US20060135559 Novel imidazoline compounds |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135554 Novel compounds |
| 06/22/2006 | US20060135553 Imidazole derivatives |
| 06/22/2006 | US20060135551 for treating or preventing conditions or diseases associated with lipoprotein metabolism |
| 06/22/2006 | US20060135544 A Suzuki coupling reaction of 2-butyl-3-(4-bromobenzyl)-1,3-diazaspiro[4.4]non-1-ene-4-one and 2-((1-trityl-1H-tetrazol-5-yl))phenylboronic acid in a basic solvent system with a palladium or nickel complex catalyst |
| 06/22/2006 | US20060135540 PPAR active compounds |
| 06/22/2006 | US20060135517 Imidazolopyridines and methods of making and using the same |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060134764 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 06/22/2006 | US20060134425 Organic luminescence device (OLED) containing both a 5,5'-spirobi(dibenzosilole) compound and a diarylaminofluorene compound; spiro compounds have improved electron-transporting property, luminescence, and durability |
| 06/22/2006 | DE102004060752A1 New heteroaryloxy-substituted phenylamino pyrimidine compounds are Rho-kinase inhibitors useful for the treatment and/or prophylaxis of cardiovascular diseases e.g. myocardial infarction and arrhythmia, erectile dysfunction and cancers |
| 06/22/2006 | CA2604463A1 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents |
| 06/22/2006 | CA2591438A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 06/22/2006 | CA2591412A1 Chromane derivatives useful as acid pump antagonists |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2591079A1 Bridged ring nk1 antagonists |
| 06/22/2006 | CA2590845A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | CA2590843A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | CA2590316A1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease |
| 06/22/2006 | CA2590294A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 06/22/2006 | CA2589886A1 Crystalline forms of a factor xa inhibitor |
| 06/22/2006 | CA2589793A1 4-(4-(imidazol-4-yl)pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 06/22/2006 | CA2589084A1 Inhibitors of akt activity |
| 06/22/2006 | CA2586543A1 Pyrazolo-heteroaryl compounds useful to treat tnf-alpha and il-1 mediated diseases |
| 06/21/2006 | EP1671971A1 Symmetric 4-pyridinium diazo compounds with a cationic or non cationic linking group, compositions comprising them , a dying process and kit thereof |
| 06/21/2006 | EP1671970A1 Substituted 1H-pyrrolo(2,3-b)pyridines and preparation thereof |
| 06/21/2006 | EP1671955A1 Cationic symmetric imidazole diazocompounds with a non cationic linking group, compositions comprising them, dying process and kit thereof |
| 06/21/2006 | EP1670802A2 Novel heterocyclic compounds as hsp90-inhibitors |
| 06/21/2006 | EP1670798A1 Aminopyridine-derivatives as inductible no-synthase inhibitors |
| 06/21/2006 | EP1670797A1 Process for the preparation of risperidone |
| 06/21/2006 | EP1670796A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 06/21/2006 | EP1670795A1 Pharmacologically active imidazo 4,5-c pyridines |
| 06/21/2006 | EP1670793A1 Antibacterial agents |
| 06/21/2006 | EP1670791A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 06/21/2006 | EP1670787A2 Cytokine inhibitors |
| 06/21/2006 | EP1670778A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 06/21/2006 | EP1670483A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 06/21/2006 | EP1670466A2 Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors |
| 06/21/2006 | EP1670456A2 Compounds, compositions and methods |